SonoScape Medical Corp. (SHE:300633)
30.34
-0.51 (-1.65%)
Apr 3, 2025, 2:45 PM CST
SonoScape Medical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 2, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
Market Capitalization | 13,061 | 20,370 | 23,460 | 12,833 | 10,443 | 9,698 | Upgrade
|
Market Cap Growth | -25.55% | -13.17% | 82.80% | 22.89% | 7.69% | -12.00% | Upgrade
|
Enterprise Value | 11,617 | 18,761 | 22,088 | 12,399 | 10,186 | 9,434 | Upgrade
|
Last Close Price | 30.33 | 46.91 | 54.21 | 31.46 | 25.48 | 23.53 | Upgrade
|
PE Ratio | 54.31 | 44.82 | 63.44 | 51.91 | - | 95.51 | Upgrade
|
Forward PE | 29.50 | 34.58 | 57.53 | 50.58 | 78.06 | 25.70 | Upgrade
|
PS Ratio | 6.38 | 9.61 | 13.31 | 8.88 | 8.98 | 7.73 | Upgrade
|
PB Ratio | 4.23 | 6.48 | 8.56 | 5.45 | 7.76 | 6.91 | Upgrade
|
P/TBV Ratio | 5.59 | 7.24 | 9.73 | 6.32 | 10.64 | 10.45 | Upgrade
|
P/FCF Ratio | 233.29 | 65.19 | 82.92 | 85.13 | 90.15 | 306.90 | Upgrade
|
P/OCF Ratio | 55.80 | 41.62 | 49.57 | 42.36 | 38.52 | 50.94 | Upgrade
|
EV/Sales Ratio | 5.67 | 8.85 | 12.53 | 8.58 | 8.76 | 7.52 | Upgrade
|
EV/EBITDA Ratio | 44.87 | 39.19 | 61.94 | 50.04 | 59.48 | 77.19 | Upgrade
|
EV/EBIT Ratio | 62.27 | 43.50 | 68.81 | 57.35 | 71.54 | 96.90 | Upgrade
|
EV/FCF Ratio | 207.49 | 60.04 | 78.07 | 82.26 | 87.93 | 298.56 | Upgrade
|
Debt / Equity Ratio | 0.13 | 0.02 | 0.08 | 0.05 | 0.33 | 0.33 | Upgrade
|
Debt / EBITDA Ratio | 1.56 | 0.15 | 0.58 | 0.41 | 2.61 | 3.77 | Upgrade
|
Debt / FCF Ratio | 7.22 | 0.23 | 0.77 | 0.74 | 3.86 | 14.58 | Upgrade
|
Asset Turnover | 0.52 | 0.58 | 0.54 | 0.55 | 0.50 | 0.59 | Upgrade
|
Inventory Turnover | 1.01 | 1.31 | 1.31 | 1.42 | 1.37 | 1.66 | Upgrade
|
Quick Ratio | 2.17 | 3.55 | 2.64 | 3.00 | 1.40 | 1.78 | Upgrade
|
Current Ratio | 3.09 | 4.62 | 3.36 | 3.84 | 1.80 | 2.23 | Upgrade
|
Return on Equity (ROE) | 7.86% | 15.44% | 14.52% | 13.36% | -3.36% | 7.48% | Upgrade
|
Return on Assets (ROA) | 2.96% | 7.37% | 6.11% | 5.13% | 3.81% | 2.86% | Upgrade
|
Return on Capital (ROIC) | 3.47% | 8.73% | 7.40% | 6.35% | 4.87% | 3.64% | Upgrade
|
Return on Capital Employed (ROCE) | 5.80% | 13.50% | 11.50% | 8.80% | 10.00% | 5.70% | Upgrade
|
Earnings Yield | 1.86% | 2.23% | 1.58% | 1.93% | -0.44% | 1.05% | Upgrade
|
FCF Yield | 0.43% | 1.53% | 1.21% | 1.18% | 1.11% | 0.33% | Upgrade
|
Dividend Yield | 1.04% | 0.68% | 0.33% | 0.40% | - | 0.11% | Upgrade
|
Payout Ratio | 59.01% | 18.20% | 15.62% | 2.24% | - | 42.31% | Upgrade
|
Buyback Yield / Dilution | -0.50% | -0.65% | -7.83% | -3.44% | 5.08% | -1.29% | Upgrade
|
Total Shareholder Return | 0.54% | 0.03% | -7.50% | -3.04% | 5.08% | -1.18% | Upgrade
|
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.